Exploring the implications of FDA’s renewed focus and commitment to expand the use of accelerated approval for gene therapy products.
Emily Marden, JD
Advertisement
Senior Counsel, Sidley Austin LLP
Articles by Emily Marden, JD
Advertisement
Latest Updated Articles
Accelerated Approval and the Promise of Gene TherapySeptember 27th 2023
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
From Study-by-Study to Portfolio Recruitment: Q&A with Gaynor Anders, Trialbee
2
ACT Brief: Portfolio-Level Recruitment Strategy, Structural Change Through Systems Thinking, and Kidney Function Preservation in IgAN
3
ACT Brief: Sponsor Accountability in Outsourcing, Biomarker Strategy in Precision Oncology, and Novel Sciatica Therapy
4
Precision Oncology Trials Need to Reflect the Complexity of Cancer Biology
5